Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Apply
Iptacopan
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step